BMS 6077 (Metaglip 2.5 mg / 500 mg)
Generic Name: glipizide/metformin
Pill imprint BMS 6077 has been identified as Metaglip 2.5 mg / 500 mg.
Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 2.5 mg / 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- BMS 6077
- 2.5 mg / 500 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Bristol-Myers Squibb
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|54868-5399||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Metaglip (glipizide / metformin)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.